Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ki Hon Lin

Orthopaedic Surgery of the Spine Carrollton, GA Medical Doctor

NPI 1851394837 CMS profile 38337

150 Clinic Ave, Ste 101, Carrollton, GA 30117

Open in the dashboard

General payments

$166,199

362 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ki Hon Lin of Carrollton, GA is reported in the CMS Open Payments database as having received $166,199 across 362 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $42,106 36
2024 General $38,175 28
2023 General $26,285 60
2022 General $33,186 77
2021 General $15,414 85
2020 General $5,081 41
2019 General $5,952 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ki Hon Lin
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Ki Hon Lin were reported at $42,106. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Ki Hon Lin Orthopaedic Surgery of the Spine median Middle half National median
2019 $5,952 $2,106 $337–$18,608 $163
2020 $5,081 $1,213 $156–$15,082 $114
2021 $15,414 $1,834 $271–$15,617 $132
2022 $33,186 $2,015 $320–$17,036 $149
2023 $26,285 $1,925 $336–$14,599 $160
2024 $38,175 $2,110 $341–$12,483 $164
2025 $42,106 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Royal Biologics $137,880 37 payments
  2. 4WEB, Inc. $20,092 206 payments
  3. Stryker Corporation $2,794 21 payments
  4. Globus Medical, Inc. $2,359 56 payments
  5. Medtronic, Inc. $2,018 14 payments
  6. VB Spine LLC $167 5 payments
  7. Medical Device Business Services, Inc. $137 1 payment
  8. Medtronic USA, Inc. $130 3 payments
  9. Orthofix Medical, Inc. $100 1 payment
  10. Spineology Inc. $79 3 payments
  11. Other $444 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $119,380 17 payments
  2. Consulting Fee $24,028 24 payments
  3. Food and Beverage $13,981 290 payments
  4. Travel and Lodging $8,173 29 payments
  5. Honoraria $500 1 payment
  6. Education $137 1 payment
Products named General payments · program years 2019–2025
  1. SPINE TRUSS SYSTEM $20,092 206 payments
  2. Bio-Reign 3D $4,200 4 payments
  3. MaxxCell $2,400 3 payments
  4. BIO-REIGN BIOACTIVE $1,800 2 payments
  5. STEALTHSTATION S8 PLATFORM $1,782 12 payments
  6. EVEREST SPINAL SYSTEM $1,533 7 payments
  7. XLIF $745 5 payments
  8. AVS NAVIGATOR $314 2 payments
  9. Hedron IA $310 12 payments
  10. EXCELSIUS GPS $279 6 payments
  11. Other $2,881 78 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 28 drugs

Part D claims

3,415

Median for Orthopedic Surgery: 203

Drug cost

$22,901

Median for Orthopedic Surgery: $1,433

Branded share of claims

27.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 539 $4,809
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 477 $3,081
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 370 $2,880
Fentanyl Generic 13 $2,592
Tramadol Hcl Generic 671 $2,149
Diclofenac Sodium Generic 73 $1,170
Pregabalin Generic 59 $656
Celecoxib Generic 39 $641
Prednisone Generic 389 $565
Cyclobenzaprine Hcl Generic 92 $512

The 10 drugs with the highest cost, of 28 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$134,152

Of which drugs: $1,232

Medicare patients

400

Average age 74

Services billed

9,497

234 women, 166 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 35%
Diabetes 34%
Chronic kidney disease 30%
Depression 20%
COPD 19%
Osteoporosis 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 81 7,821 $782
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 26 248 $186
Injection, methylprednisolone acetate, 80 mg J1040 Office 25 27 $154
Injection, ketorolac tromethamine, per 15 mg J1885 Office 88 118 $58
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml A9579 Office 23 23 $25

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XTAMPZA
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

362 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record